BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2764758)

  • 1. Selective removal of triglyceride-rich lipoproteins by plasmapheresis in diabetic patients with severe hypertriglyceridemia.
    Ito H; Naito C; Hayashi H; Kawamura M; Miyazaki S
    Artif Organs; 1989 Jun; 13(3):190-6. PubMed ID: 2764758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis, and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia.
    Homma Y; Mikami Y; Tamachi H; Nakaya N; Nakamura H; Goto Y
    Metabolism; 1987 May; 36(5):419-25. PubMed ID: 3574132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis in conjunction with the dextran sulfate cellulose column for hypertriglyceridemic patient: a comparison with familial hypercholesterolemia.
    Ito H; Okada H; Kakuta S; Fujisawa K; Nagase M; Naito C
    Blood Purif; 1991; 9(2):85-91. PubMed ID: 1760146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal.
    Franceschini G; Busnach G; Vaccarino V; Calabresi L; Gianfranceschi G; Sirtori CR
    Atherosclerosis; 1988 Oct; 73(2-3):197-202. PubMed ID: 2461207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel system of LDL apheresis combining a centrifugal plasma separator with a specific LDL adsorption column.
    Nakajima T; Nakamura T; Funahashi T; Kanai H; Kurata Y; Matsuzawa Y; Tarui S
    Atherosclerosis; 1988 Oct; 73(2-3):143-8. PubMed ID: 3190816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis.
    Homma Y; Mikami Y; Tamachi H; Nakaya N; Nakamura H; Araki G; Goto Y
    Atherosclerosis; 1986 Apr; 60(1):23-7. PubMed ID: 2423096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants.
    Yeh JH; Lee MF; Chiu HC
    J Clin Apher; 2003; 18(1):32-6. PubMed ID: 12717791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of serum lipid abnormalities in chronic hemodialysis.
    Brunzell JD; Albers JJ; Haas LB; Goldberg AP; Agadoa L; Sherrard DJ
    Metabolism; 1977 Aug; 26(8):903-10. PubMed ID: 195181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen.
    Otto C; Richter WO; Schwandt P
    Metabolism; 2000 Jun; 49(6):810-3. PubMed ID: 10877212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
    Wang T; Xu B; Fan R; Liu Z; Gong D
    J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis.
    Nakagawa M; Kimura S; Fujimoto K; Atumi H; Imura J; Chikazawa Y; Imamura H; Okuyama H; Yamaya H; Fukushima T; Nakagawa A; Asaka M; Yokoyama H
    Ther Apher Dial; 2008 Dec; 12(6):509-13. PubMed ID: 19140851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients.
    Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC
    Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma separation using a membrane.
    Hirano R; Namazuda K; Suemitsu J; Harashima T; Hirata N
    Transfus Apher Sci; 2017 Oct; 56(5):649-653. PubMed ID: 28923773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
    Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
    Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL apheresis reduces the susceptibility of LDL to in vitro oxidation in a diabetic patient with hemodialysis treatment.
    Inoue I; Takahashi K; Kikuchi C; Katayama S
    Diabetes Care; 1996 Oct; 19(10):1103-7. PubMed ID: 8886556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.